Regulation of Transforming Growth Factor β–Activated Kinase Activation by Epigallocatechin‐3‐Gallate in Rheumatoid Arthritis Synovial Fibroblasts: Suppression of K⁶³‐Linked Autoubiquitination of Tumor Necrosis Factor Receptor–Associated Factor 6

Abstract

Our findings provide a rationale for targeting TAK1 for the treatment of RA with EGCG.